111 related articles for article (PubMed ID: 2787808)
41. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
Manvelian G; Daniels S; Gibofsky A
Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
[TBL] [Abstract][Full Text] [Related]
43. Clinical pharmacokinetics of oxaprozin.
Davies NM
Clin Pharmacokinet; 1998 Dec; 35(6):425-36. PubMed ID: 9884815
[TBL] [Abstract][Full Text] [Related]
44. [Pranoprofen-induced lung injury manifesting as acute eosinophilic pneumonia].
Fujimori K; Shimatsu Y; Suzuki E; Gejyo F; Arakawa M
Nihon Kokyuki Gakkai Zasshi; 1999 May; 37(5):401-5. PubMed ID: 10410543
[TBL] [Abstract][Full Text] [Related]
45. Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen Study Group.
Notivol R; Martínez M; Bergamini MV
Am J Ophthalmol; 1994 May; 117(5):651-6. PubMed ID: 8172273
[TBL] [Abstract][Full Text] [Related]
46. Design and Evaluation of a Dual-Sensitive In Situ Gel for the Controlled Release of Pranoprofen.
Yang H; Ding S; Fan D; Zhu Z; Fan Y; Li J; Wang D
AAPS PharmSciTech; 2024 Feb; 25(2):35. PubMed ID: 38332223
[TBL] [Abstract][Full Text] [Related]
47. Plasma pharmacokinetics of cinmetacin following oral administration in healthy volunteers.
Danesi R; Ducci M; Acerbi D; Del Tacca M
Arzneimittelforschung; 1988 Jan; 38(1):129-31. PubMed ID: 3259136
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of tiaprofenic acid in elderly multimorbid patients.
Platt D; Eicher H; Rieck W; Hilgert D
Drugs; 1988; 35 Suppl 1():53-6. PubMed ID: 3359947
[No Abstract] [Full Text] [Related]
49. Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.
Davies NM
Clin Pharmacokinet; 1996 Nov; 31(5):331-47. PubMed ID: 9118583
[TBL] [Abstract][Full Text] [Related]
50. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetics of tiaprofenic acid in humans: lack of stereoselectivity in plasma using both direct and precolumn derivatization methods.
Vakily M; Jamali F
J Pharm Sci; 1996 Jun; 85(6):638-42. PubMed ID: 8773962
[TBL] [Abstract][Full Text] [Related]
52. Application of column-switching HPLC method in evaluating pharmacokinetic parameters of zaltoprofen and its salt.
Yang HK; Kim SY; Kim JS; Sah H; Lee HJ
Biomed Chromatogr; 2009 May; 23(5):537-42. PubMed ID: 19101928
[TBL] [Abstract][Full Text] [Related]
53. Pharmacokinetic study of fentiazac and its main metabolite hydroxyfentiazac in the elderly.
Houin G; Lapeyre C; Rochas MA; Tufenkji AE; Campistron G; Coulais Y; Akbaraly JP; Grislain L; Beck H
Arzneimittelforschung; 1993 Jan; 43(1):50-3. PubMed ID: 8447848
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of sustained action tiaprofenic acid in elderly arthritic patients.
Hosie GA; Hosie J
Drugs; 1988; 35 Suppl 1():52. PubMed ID: 3359946
[No Abstract] [Full Text] [Related]
55. Single-dose and multiple-dose pharmacokinetics and dose proportionality of intravenous and intramuscular HPβCD-diclofenac (Dyloject) compared with other diclofenac formulations.
Mermelstein F; Hamilton DA; Wright C; Lacouture PG; Ramaiya A; Carr DB
Pharmacotherapy; 2013 Oct; 33(10):1012-21. PubMed ID: 23744759
[TBL] [Abstract][Full Text] [Related]
56. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
[TBL] [Abstract][Full Text] [Related]
57. [Influence of fever on cefotaxime pharmacokinetics].
Demotes-Mainard F; Albin H; Ragnaud JM; Gin H; Vincon G; Aubertin J
Pathol Biol (Paris); 1988 Feb; 36(2):155-8. PubMed ID: 3279384
[TBL] [Abstract][Full Text] [Related]
58. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
Nichol FE; Samanta A; Rose CM
Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
[TBL] [Abstract][Full Text] [Related]
59. Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.
Lima DR; Santos RM; Werneck E; Andrade GN
Eur J Drug Metab Pharmacokinet; 1991; 16(3):161-70. PubMed ID: 1814733
[TBL] [Abstract][Full Text] [Related]
60. Pharmacokinetics of pirprofen and its pyrrol metabolite in elderly patients.
Rossi FA; Ferrero M; Balladore GE; Zecca L; Fraschini F; Ferrario P; Bichisao E; Monza GC; Maresca V
Eur J Clin Pharmacol; 1988; 35(4):379-83. PubMed ID: 3197745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
